The GLP is committed to full transparency. Download and review our Annual Report.

Nex-gen technologies expand sequencing options for doctors

| | March 12, 2015

Genetic data has gone the way of fast food: It’s cheap, speedy, and widely available. And that’s a good thing, because the sequence of bases—the As, Cs, Gs, and Ts that comprise DNA—contains a lot of information. Doctors can use that sequence to track changes in cancer cells as they mutate, researchers can use it to discover new disease-associated genes, and nonscientists can use it to divine their medical destiny. Next-gen sequencing machines make all that possible—and they use a couple of different technologies to get it right.

Illumina’s machines can resolve a person’s full genome for under $1,000—an appealing combination for researchers who are combing our DNA for genes associated with various traits. The company is also the go-to choice of personal-genome companies like Gentle. The HiSeq X works by unzipping DNA helices and rebuilding one side with fluorescent-tagged bases that a special camera can see and count.

But doctors and genetic counselors looking for specific information—about a particular disease-causing mutation, say—don’t always need the entire genome. The exome, which is the 1 percent of the genome that encodes proteins, is enough. The Thermo Fisher Ion Proton works with pH instead of light: When two complementary bases stick together, they throw off hydrogen ions, which register as a tiny increase in acidity.

Read full original article: How two different gene sequencers comb through DNA

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend